Motion Sickness Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going Vessels
Conditions:   Prevention of Nausea Associated With Motion Sickness;   Treatment of Nausea Associated With Motion Sickness Interventions:   Drug: Scopolamine Transdermal Patch [Transderm Scop];   Drug: Scopolamine;   Drug: Placebo Patch;   Drug: Placebo Gel Sponsor:   Naval Aeromedical Research Unit, Dayton Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2019 Category: Research Source Type: clinical trials